High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated With Direct-Acting Antivirals

Press/Media: Press / Media

PeriodApr 15 2016

Media coverage

1

Media coverage

  • TitleHigh Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated With Direct-Acting Antivirals
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date4/15/16
    PersonsEric J Lawitz